Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 21:16:1599070.
doi: 10.3389/fmicb.2025.1599070. eCollection 2025.

Global prevalence and antibiotic resistance profiles of carbapenem-resistant Pseudomonas aeruginosa reported from 2014 to 2024: a systematic review and meta-analysis

Tsepo Ramatla  1 , Jane Nkhebenyane  1 , Kgaugelo E Lekota  2 , Oriel Thekisoe  2 , Maropeng Monyama  3 , Conrad Chibunna Achilonu  4 , George Khasapane  1
Affiliations

Global prevalence and antibiotic resistance profiles of carbapenem-resistant Pseudomonas aeruginosa reported from 2014 to 2024: a systematic review and meta-analysis

Tsepo Ramatla et al. Front Microbiol. .

Abstract

Introduction: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) represents a global threat, but the global distribution of carbapenem resistant bacteria remains a critical issue in public health.

Methods: We conducted a systematic review and meta-analysis on the global pooled prevalence estimate (PPE) of CRPA and their antibiotic resistance. The systematic review protocol was registered with PROSPERO (CRD42024579654). This study was carried out following the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Heterogeneity between studies was assessed using Cochrane Q test and I2 test statistics based on the random effects model. Comprehensive meta-analysis software v4.0 was used to analyze the pooled prevalence of CRPA.

Results: A total of 163 studies (both clinical and screening samples) containing a total of 58,344 cases from 39 countries were included in this study. The overall PPE of CRPA was 34.7% (95% CI: 0.316-0.37.8) for both clinical and screening samples. Meropenem had a PPE of 31.2% (95% CI: 0.272-0.352) and imipenem had the lowest PPE of 27.7% (95% CI: 0.238-0.319). Japan had the highest PPE at 98.2% (95% CI: 0.482-0.100) of CRPA, and the lowest was observed for Saudi Arabia at 13.9% (95% CI: 0. 064-0. 277). CRPA is widespread on five continents except Australia and Antarctica, while the highest PPE is in Europe at 47.6% (95% CI: 0.359-0.595) and the lowest in Asia at 32, 8% (95% CI: 0.293-0.364). The relatively higher PPE of CRPA was observed in Europe during the year interval 2014-2017 at 95.4% (95% CI: 0.388-0.999), followed by Africa from the year 2022-2024 with 38.5% (95% CI: 0.243-0.550). Ceftazidime was significantly higher in studies conducted before 2019 with a PPE of 44.7% (95% CI: 0.246% - 0.668), while CRPA after 2019 had a higher resistance to cefoperazone/sulbactam with a PPE of 17.3% (95% CI: 0.050-0.455).

Discussion: This review indicates that the prevalence of CRPA is generally high and varies significantly between countries. To prevent the emergence of CRPA and antibiotic resistance, future initiatives should prioritise strengthening laboratory capacity for early detection of antibiotic resistance.

Keywords: CRPA; antibiotic resistance; global; meta-analysis; pooled prevalence estimate.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The PRISMA diagram shows the study selection process.
Figure 2
Figure 2
Forest plot showing the pooled estimates of multidrug resistance of carbapenem-resistant-P. aeruginosa globally. The diamond at the base indicates the pooled estimates from the overall studies.
Figure 3
Figure 3
Forest plot showing mortality prevalence in carbapenem resistance-P. aeruginosa. The diamond at the base indicates the pooled estimates from the overall studies.
See this image and copyright information in PMC

References

    1. Abdalhamid B., Elhadi N., Alabdulqader N., Alsamman K., Aljindan R. (2016). Rates of gastrointestinal tract colonization of carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa in hospitals in Saudi Arabia. New Microbes New Infect. 10, 77–83. doi: 10.1016/j.nmni.2016.01.014, PMID: - DOI - PMC - PubMed
    1. Abubakar U., Zulkarnain A. I., Rodríguez-Baño J., Kamarudin N., Elrggal M. E., Elnaem M. H., et al. (2022). Treatments and predictors of mortality for carbapenem-resistant gram-negative bacilli infections in Malaysia: a retrospective cohort study. Trop. Med. Infect. Dis. 7:415. doi: 10.3390/tropicalmed7120415, PMID: - DOI - PMC - PubMed
    1. Acar A., Karaahmetoğlu G., Akalın H., Altay A. F. (2019). Pooled prevalence and trends of antimicrobial resistance in Pseudomonas aeruginosa clinical isolates over the past 10 years in Turkey: a meta-analysis. J. Glob. Antimicrob. Resist. 18, 64–70. doi: 10.1016/j.jgar.2019.01.032, PMID: - DOI - PubMed
    1. Al-Abedi K. J. H., Al-Mayahi F. A. (2019). Molecular detection of serine carbapenemase genes in carbapenem-resistant isolates of Pseudomonas aeruginosa recovered from patients in Al-Diwaniyah Province, Iraq. Iraq J. Pure Appl. Microbiol. 13, 1775–1782. doi: 10.22207/JPAM.13.3.53 - DOI
    1. Andersson D. I., Hughes D. (2017). Selection and transmission of antibiotic-resistant bacteria. Microbiol. Spectr. 5:MTBP0013-2016. doi: 10.1128/microbiolspec.mtbp-0013-2016, PMID: - DOI - PMC - PubMed

Publication types

LinkOut - more resources